Urology of Indiana Urologic Oncologists, Eugene Cone, MD and Chad Reichard, MD , were recently referenced in numerous urology, medical and business media stories discussing UOI’s role as one of the first in the U.S. to provide and dose recombinant Bacillus Calmette-Guérin (rBCG) for bladder cancer patients. This will help UOI address the chronic shortages and difficulty associated with getting BCG for our vulnerable bladder cancer population.
Through UOI’s partnership with US Urology Partners, the rapid expansion and growth of our research program and advanced therapy capability brings a superior level of urologic care to patients across the state of Indiana. Congratulations to Drs. Reichard and Cone, who are also UOI’s Research Co-Directors.
You can view each article on this topic following the individual links below:
- Uro Today: https://tinyurl.com/bdz8dk2z
- Cure Today: https://tinyurl.com/2pm99sn5
- Markets/Business Insider: https://tinyurl.com/2uf3fptz
- Urology Times: https://tinyurl.com/yr79evwe
- Urology Times (Other): https://tinyurl.com/4t76s8f7